Nykode Therapeutics CEO after another million-dollar deal: We have no competitors
![Michael Engsig began his career in Norwegian Vaccibody as COO. Today, he has sealed another million.dollar deal as the company's CEO. | Photo: Vaccibody / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13493433.ece/ALTERNATES/schema-16_9/doc7ijbbzqq3tfjcbc1lbc.jpg)
Some of the biggest biotech players in the world are swarming around the Norwegian company Nykode Therapeutics, which was named Vaccibody until yesterday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
New Sanofi study is yet another win for blockbuster drug
For subscribers
Anthony Mancini will help Genmab take its next steps
For subscribers
Stockholm wants to become leading life science region
For subscribers